American Journal of Kidney Diseases
Volume 53, Issue 3 , Pages 475-491 , March 2009

Facility Hemodialysis Vascular Access Use and Mortality in Countries Participating in DOPPS: An Instrumental Variable Analysis

  • Ronald L. Pisoni, PhD

      Affiliations

    • Arbor Research Collaborative for Health, Ann Arbor, MI
    • Corresponding Author InformationAddress correspondence to Ronald L. Pisoni, PhD, Arbor Research Collaborative for Health, 315 W Huron, Ste 360, Ann Arbor, MI 48103
    • ,
  • Charlotte J. Arrington, MPH

      Affiliations

    • Arbor Research Collaborative for Health, Ann Arbor, MI
    • ,
  • Justin M. Albert, BS

      Affiliations

    • Arbor Research Collaborative for Health, Ann Arbor, MI
    • ,
  • Jean Ethier, MD

      Affiliations

    • Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada
    • ,
  • Naoki Kimata, MD

      Affiliations

    • Tokyo Women's Medical University, Tokyo, Japan
    • ,
  • Mahesh Krishnan, MD

      Affiliations

    • Amgen Inc, Thousand Oaks, CA
    • ,
  • Hugh C. Rayner, MD

      Affiliations

    • Heart of England NHS Foundation Trust, Birmingham, United Kingdom
    • ,
  • Akira Saito, MD, PhD

      Affiliations

    • Tokai University, Kanagawa, Japan
    • ,
  • Jeffrey J. Sands, MD

      Affiliations

    • Fresenius Medical Care NA, Celebration, FL
    • ,
  • Rajiv Saran, MD

      Affiliations

    • University of Michigan, Ann Arbor, MI
    • ,
  • Brenda Gillespie, PhD

      Affiliations

    • University of Michigan, Ann Arbor, MI
    • ,
  • Robert A. Wolfe, PhD

      Affiliations

    • Arbor Research Collaborative for Health, Ann Arbor, MI
    • ,
  • Friedrich K. Port, MD

      Affiliations

    • Arbor Research Collaborative for Health, Ann Arbor, MI

Received 25 February 2008 ,Accepted 15 October 2008.

References 

  1. Kidney Disease: Improving Global Outcomes (KDIGO). http://www.kdigo.org/clinical-practice-guidelines/guideline-target-rationales#vaAccessed September 25, 2007
  2. Tordoir J, Canaud B, Haage P, et al. EBPG on vascular access. Nephrol Dial Transplant. 2007;22(suppl 2):Sii88–Sii117
  3. Mactier R. The Renal Association Clinical Practice Guidelines. http://www.renal.org/guidelines/module3a.html#VascularAccessAccessed October 10, 2007
  4. Centers for Medicare & Medicaid Services. 2006 Annual Report, End Stage Renal Disease Clinical Performance Measures Project. Baltimore, MD: Department of Health and Human Services, Centers for Medicare & Medicaid Services, Office of Clinical Standards & Quality; 2007;
  5. Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int. 2002;61:305–316
  6. Pisoni RL, Young EW, Mapes DL, Keen ML, Port FK. Vascular access use and outcomes in the U.S., Europe, and Japan: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol News Issues. 2003;17:38–47
  7. Combe CH, Pisoni RL, Port FK, et al. Dialysis Outcomes and Practice Patterns Study: Données sur l'utilisation des cathéters veineux centraux en hémodialyse chronique. Nephrologie. 2001;22:379–384
  8. Dhingra RK, Young EW, Hulbert-Shearon TE, et al. Type of vascular access and mortality in US hemodialysis patients. Kidney Int. 2001;60:1443–1451
  9. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62:620–626
  10. Xue JL, Dahl D, Ebben JP, Collins AJ. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis. 2003;42:1013–1019
  11. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: A propensity score analysis. J Am Soc Nephrol. 2004;15:477–486
  12. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J. CHOICE Study: Type of vascular access and survival among incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005;16:1449–1455
  13. Allon M, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis. 2006;47:469–477
  14. Thomson PC, Stirling CM, Geddes CC, Morris ST, Mactier RA. Vascular access in haemodialysis patients: A modifiable risk factor for bacteraemia and death. QJM. 2007;100:415–422
  15. Bradbury BD, Fissell RB, Albert JM, et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2007;2:89–99
  16. Schneeweiss S, Solomon DH, Wang PS, Rassen J, Brookhart MA. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: An instrumental variable analysis. Arthritis Rheum. 2006;54:3390–3398
  17. Brookhart MA, Wang PS, Solomon DH, Schneeweiss S. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology. 2006;17:268–275
  18. Brooks JM, Irwin CP, Hunsicker LG, Flanigan MJ, Chrischilles EA, Pendergast JF. Effect of dialysis center profit-status on patient survival: A comparison of risk-adjustment and instrumental variable approaches. Health Services Res. 2006;41:2267–2289
  19. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias (Effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods). JAMA. 2007;297:278–285
  20. Angrist JD, Imbens GW. Two-stage least squares estimation of average causal effects in models with variable treatment intensity. J Am Stat Assoc. 1995;90:431–442
  21. Johnston SC. Combining ecological and individual variables to reduce confounding by indication: Case study—Subarachnoid hemorrhage treatment. J Clin Epidemiol. 2000;53:1236–1241
  22. Young EW, Goodkin DA, Mapes DL, et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study. Kidney Int Suppl. 2000;74:S74–S81
  23. Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner M, Wolfe RA. The Dialysis Outcomes and Practice Patterns Study: Design, data elements, and methodology. Am J Kidney Dis. 2004;44(suppl 2):S7–S15
  24. Klein J, Moeschberger M. Survival Analysis Techniques for Censored and Truncated Data. In: New York, NY: Springer; 1997;p. 416–418
  25. Johnston J, DiNardo J. Econometric Methods. (ed 4). New York, NY: McGraw Hill; 1998;
  26. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: A multicenter retrospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol. 1998;9:869–876
  27. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int. 1999;55:1081–1090
  28. Jean G, Charra B, Chazot C, et al. Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias. Nephron. 2002;91:399–405
  29. Stevenson KB, Adcox MJ, Mallea MC, Narasimhan N, Wagnild JP. Standardized surveillance of hemodialysis vascular access infections: 18-Month experience at an outpatient, multifacility hemodialysis center. Infect Control Hosp Epidemiol. 2000;21:200–203
  30. Gulati S, Sahu KM, Avula S, Sharma RK, Ayyagiri A, Pandey CM. Role of vascular access as a risk factor for infections in hemodialysis. Ren Fail. 2003;25:967–973
  31. George A, Tokars JI, Clutterbuck EJ, Bamford KB, Pusey C, Holmes AH. Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: Prospective study. BMJ. 2006;332:1435
  32. Troidle L, Eisen T, Pacelli L, Finkelstein F. Complications associated with the development of bacteremia with Staphylococcus aureus. Hemodial Int. 2007;11:72–75
  33. Inrig JK, Reed SD, Szczech LA, et al. Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. Clin J Am Soc Nephrol. 2006;1:518–524
  34. Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 Study. Kidney Int. 2005;68:311–318
  35. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000;29:722–729
  36. Newhouse JP, McClellan M. Econometrics in outcomes research: The use of instrumental variables. Annu Rev Public Health. 1998;19:17–34
  37. Wolfe RA, Hulbert-Shearon TE, Ashby VB, Messana JM. Decreases in catheter use are associated with decreases in mortality for dialysis facilities during 2000-03. J Am Soc Nephrol. 2005;16:95A;(abstr)
  38. Ethier J, Mendelssohn DC, Elder SJ, et al. Vascular access use and outcomes: An international perspective: Results from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2008;23:3219–3226
  39. Sands JJ. Increasing AV fistulae and decreasing dialysis catheters: Two aspects of improving patient outcomes. Blood Purif. 2007;25:99–102
  40. Lacson E, Lazarus JM, Himmelfarb J, Ikizler TA, Hakim RM. Balancing Fistula First with catheters last. Am J Kidney Dis. 2007;50:379–395
  41. Engemann JJ, Friedman JY, Reed SD, et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol. 2005;26:534–539
  42. Greenwood RN, Ronco C, Gastaldon F, et al. Erythropoietin dose variation in different facilities in different countries and its relationship to drug resistance. Kidney Int Suppl. 2003;87:S78–S86
  43. Roberts TL, Obrador GT, St Peter WL, Pereira BJ, Collins AJ. Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients. Kidney Int. 2004;66:2429–2436
  44. Kaysen GA, Kumar V. Inflammation in ESRD: Causes and potential consequences. J Ren Nutr. 2003;13:158–160
  45. Pisoni RL, Bragg-Gresham JL, Young EW, et al. Anemia management outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44:94–111
  46. Yoshino M, Kuhlmann MK, Greenwood RN, et al. International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol. 2006;17:3510–3519

 Originally published online as doi:10.1053/j.ajkd.2008.10.043 on January 16, 2009.

PII: S0272-6386(08)01619-3

doi: 10.1053/j.ajkd.2008.10.043

American Journal of Kidney Diseases
Volume 53, Issue 3 , Pages 475-491 , March 2009

Article Tools

* Image Usage & Resolution